RuCu Nanosheets with Ultrahigh Nanozyme Activity for Chemodynamic Therapy

Adv Healthc Mater. 2023 Sep;12(23):e2300490. doi: 10.1002/adhm.202300490. Epub 2023 Apr 29.

Abstract

Nanoenzymes have been widely explored for chemodynamic therapy (CDT) in cancer treatment. However, poor catalytic efficiency of nanoenzymes, especially in the tumor microenvironment with insufficient H2 O2 and mild acidity, limits the effect of CDT. Herein, a new ultrathin RuCu nanosheet (NS) based nanoenzyme which has a large specific surface area and abundant channels and defects is developed. The RuCu NSs show superb catalytic efficiency for the oxidation of peroxidase substrate H2 O2 at a wide range of pH and their catalytic efficiency (kcat /Km = 177.2 m-1 s-1 ) is about 14.9 times higher than that of the single-atom catalyst FeN3 P. Besides being an efficient nanozyme as peroxidase, the RuCu NSs possess other two enzyme activities, not only disproportionating superoxide anion to produce H2 O2 but also consuming glutathione to keep a high concentration of H2 O2 in the tumor microenvironment for Fenton reaction. With these advantages, the RuCu NSs exhibit good performance to kill cancer cells and inhibit tumor growth in mice, demonstrating a promising potential as new CDT reagent.

Keywords: Fenton reaction; RuCu nanosheets; chemodynamic therapy; nanozymes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Catalysis
  • Cell Line, Tumor
  • Glutathione
  • Hydrogen Peroxide
  • Mice
  • Neoplasms* / drug therapy
  • Peroxidase*
  • Peroxidases
  • Superoxides
  • Tumor Microenvironment

Substances

  • Peroxidase
  • Peroxidases
  • Glutathione
  • Superoxides
  • Hydrogen Peroxide